Search
Citations & References (13)
Gibco™
StemPro™ MSC SFM XenoFree
StemPro MSC SFM XenoFree is a serum-free medium for the growth and expansion of mesenchymal stem cell (MSCs) derived fromRead more
| Catalog Number | Quantity |
|---|---|
| A1067501 | 1 Kit |
Catalog number A1067501
Price (TWD)
16,800.00
Online offer
Ends: 31-Dec-2025
21,000.00Save 4,200.00 (20%)
Each
Quantity:
1 Kit
Price (TWD)
16,800.00
Online offer
Ends: 31-Dec-2025
21,000.00Save 4,200.00 (20%)
Each
StemPro MSC SFM XenoFree is a serum-free medium for the growth and expansion of mesenchymal stem cell (MSCs) derived from a variety of tissue sources. MSCs can be expanded for multiple passages while maintaining trilineage mesoderm differentiation potential. This medium supports scale-up 3D cell culture using microcarriers and extracellular vesicle production under serum-free and xeno-free conditions.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Cell TypeMesenchymal Stem Cells
Culture EnvironmentCO2
Included AntibioticsNo antibiotics
Product LineStemPro
Product TypeStem Cell Serum Free Media (SFM)
Purity or Quality GradeMS Cell-Qualified
Quantity1 Kit
SpeciesHuman
ClassificationXeno-free
Culture TypeAdherent Cell Culture
FormLiquid
Serum LevelSerum-free
Without AdditivesNo Glutamine, No Phenol Red
Unit SizeEach
Contents & Storage
Each kit contains 1 x 500 ml StemPro™ MSC SFM Basal Medium and 1 X 5 ml StemPro™ MSC SFM XenoFree Supplement. StemPro™ MSC SFM Basal Medium is stored at 2 to 8°C and stable for 12 months. The StemPro™ MSC SFM XenoFree Supplement is stored frozen at -5 to -20°C and stable for 12 months.
Frequently asked questions (FAQs)
What is the concentration of sodium bicarbonate in StemPro MSC SFM XenoFree?
Citations & References (13)
Citations & References
Abstract
Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity.
Journal:Molecular therapy : the journal of the American Society of Gene Therapy
PubMed ID:30341012
Exosomes can deliver therapeutic RNAs to neurons. The composition and the safety profile of exosomes depend on the type of the exosome-producing cell. Mesenchymal stem cells are considered to be an attractive cell type for therapeutic exosome production. However, scalable methods to isolate and manufacture exosomes from mesenchymal stem cells
Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles.
Journal:Journal of molecular medicine (Berlin, Germany)
PubMed ID:27638341
ABSTRACT: Growing evidence indicates that intracellular signaling mediated by extracellular vesicles (EVs) released by stem cells plays a considerable role in triggering the regenerative program upon transplantation. EVs from umbilical cord mesenchymal stem cells (UC-MSC-EVs) have been shown to enhance tissue repair in animal models. However, translating such results into
Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
Journal:Tissue engineering. Part C, Methods
PubMed ID:21895491
The immunomodulatory properties of mesenchymal stem cells (MSCs) make them attractive therapeutic agents for a wide range of diseases. However, the highly demanding cell doses used in MSC clinical trials (up to millions of cells/kg patient) currently require labor intensive methods and incur high reagent costs. Moreover, the use of
A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.
Journal:
PubMed ID:26136376
'Human mesenchymal stem/stromal cells (MSC) are promising candidates for cell-based therapies and the development of microcarrier-based cultures in scalable bioreactors with well-defined xenogeneic-free components represent important milestones towards the clinical-scale production of these cells. In this work, we optimized our previously developed xeno-free microcarrier-based system for the scalable expansion of
Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.
Journal:
PubMed ID:26564250
'Due to their immunosuppressive properties, mesenchymal stem cells (MSC) have been evaluated for the treatment of immunological diseases. However, the animal-derived growth supplements utilized for MSC manufacturing may lead to clinical complications. Characterization of alternative media formulations is imperative for MSC therapeutic application. Human BMMSC and AdMSC were expanded in